Collaborations and clinical advances mark progress in gene editing and therapeutic development. Abu Dhabi’s DoH joined forces with UCSF and Innovative Genomics Institute to establish genome medicine centers focusing on severe rare diseases using CRISPR technologies. Separately, an AAV-OTOF gene therapy trial in China restored hearing in children and adults with inherited deafness, showing rapid and meaningful improvements. These efforts exemplify expanding applications of gene editing and personalized medicine.